<img src="https://secure.imaginative-trade7.com/791214.png" style="display:none;">

OpenSky Uptake Intelligence

AI Powered Insight for Improving Therapy and Vaccination Adoption.

OpenSky Uptake Intelligence combines real-world data, AI, and expert consulting to help pharmaceutical and healthcare teams understand what drives or hinders adoption — and act on it.

Trusted by

MSD logo
Microsoft-Logo-2048x1152

Empowering Market Access Teams to drive real-world adoption and measurable impact.

Market Access leaders are under growing pressure to show that therapies and vaccines not only reach patients but also deliver measurable value across populations.
Yet data silos, limited visibility on campaign impact, and slow feedback cycles often make it difficult to demonstrate where adoption gaps exist, what’s driving them, and which actions truly improve outcomes.

Are you struggling to quantify the impact of education, engagement, or access programs?

Do you need clearer insight into what drives or hinders adoption across different markets?

Is it difficult to align internal teams around one trusted view of performance?

Do you lack a fast, evidence-based feedback loop to measure real-world results and plan next steps?

Uptake Intelligence gives Market Access leaders a complete, evidence-based view of therapy and vaccine adoption — revealing the social, behavioural, and healthcare factors that drive outcomes.

Built on Microsoft Fabric, Azure AI, and Power BI, it turns complex data into actionable insight — connecting Market Access, Medical, and Commercial teams around measurable outcomes.

teenager vaccination
  • Quantify real-world adoption barriers and enablers.
  • Measure intervention effectiveness in weeks, not months.
  • Recommend explainable, next-best actions for your markets.
  • Connect data and teams across the value and access ecosystem.
slovakia flag

Proven Impact

60% year-on-year vaccination improvement

OpenSky Uptake Intelligence was used to analyse vaccination adoption for HPV in Slovakia, uncovering real-world drivers and barriers for MSD.
These insights guided targeted interventions that led to a 60% increase in vaccination coverage in just one year — demonstrating measurable impact through data-driven strategy.

First national vaccination uptake dashboard

Created, giving real-time visibility by region, gender, and provider type.

Insights guided targeted outreach

Improving awareness and equity across priority populations.

Joint project with MSD and the Ministry of Health Slovakia

Showcasing the power of cross-sector data collaboration.

About Uptake Intelligence

Uptake Intelligence is OpenSky’s AI-driven insight engine and consulting service that helps pharmaceutical teams understand, predict and improve real-world therapy and vaccine uptake.  Built for Market Access, Medical, and Commercial leaders, the platform connects fragmented data, field insights, and intervention outcomes into one continuous pathway.

Uptake Intelligence Imagery (1)

How It Works

From Data to Decision...a continuous intelligence cycle.

 

 

The Uptake Intelligence Engine transforms complex real-world data into clear, actionable insight through a proven, six-step data-to-decision cycle.  The engine continually learns. Each new data refresh retrains the AI models, integrating fresh outcomes and feedback to enhance accuracy and insight relevance.

 

 

OpenSky Uptake Intelligence - How the Engine Works (4)

Uptake Intelligence Engine - The Process

Number 1

Ingest & Connect

Integrate internal and external sources (CRM, registry, claims, public health) securely in Microsoft Fabric.

2-Oct-30-2025-01-14-53-4526-PM

Analyze & Identify

AI uncovers behavioural, social, and clinical factors influencing adoption.

3-3

Measure & Evaluate

Quantify the real-world impact of interventions and equity progress.

4-2

Recommend & Optimize

AI agents propose targeted recommendations, validated by OpenSky consultants.

5-3

Visualize & Collaborate

Power BI dashboards enable collaboration around shared insight.

Cycle Icon

Learn & Evolve

Continuous learning and retraining ensure the model grows smarter over time.

Fast, Focused Results

From Data to Decision in Weeks

An engagement combines AI-driven analytics with human-led consulting to translate real-world data into clear, actionable insight.

Typical projects deliver measurable outcomes in 8–12 weeks, helping teams move quickly from discovery to visualised results — securely and at scale.

 

8-12
ABOUT US

More of Our Pharma Data Work

DENMARK MAP
Engage with the Denmark HPV Immunization Dashboard
OpenSky MSD Research Report Heatmap
Download the Report
map of switzerland

Advancing Vaccine Data Awareness in Switzerland

Switzerland faces unique challenges in vaccination monitoring, with fragmented systems across its 26 cantons and limited national coordination for Electronic Vaccination Registries (EVRs).
To support greater alignment among healthcare, policy, and public-health stakeholders, OpenSky conducted stakeholder consulting in Switzerland, sharing European insights and best practices to advance national strategies for vaccine monitoring and data-led public health improvement.

Webinar: How Data Intelligence is Driving Vaccine Uptake in Pharma and Public Health

  Thurs 22nd January, 11am-12.30pm CET    Microsoft Teams

Opensky_Logo_CMYK-1
MSD logo
Global_Health_Connector_RGB_LOGO_FORMERLY_DARK
ABOUT US

Why OpenSky

iStock-168646391

Experience

Over 20 years delivering complex data transformation projects across healthcare, pharma, and public-sector systems — including long-term partnerships with MSD and other industry leaders.

 

Microsoft-Logo-2048x1152

Technology

Built on Microsoft Fabric and Azure AI, providing a scalable, secure, and compliant architecture for healthcare analytics and cross-functional collaboration.

iStock-1354578539

Impact

Proven results from national-scale projects such as vaccination uptake analytics, public health data reporting, and AI-powered adoption intelligence, improving access, equity, and patient outcomes.

learning and development

Insight

Expertise in transforming clinical, epidemiological, and behavioural data into actionable intelligence for Market Access, Medical, and Policy teams — supported by our in-house R&D department and collaborations with leading research and innovation centres including: CeADAR (Ireland’s National Centre for Applied AI), The Alan Turing Institute and the Global Health Connector Partnership.